AKTX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 04:00):

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases...

Stats
今日成交量	22 004.00
平均成交量	11 858.00
市值	7.84M
EPS	$2.00 ( 2023-10-03 )
下一个收益日期	( $0 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.630
ATR14	$0.0270 (2.11%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-01	Jacques Rachelle Suzanne	Sell	0	Ordinary Shares, par value $0.0001 per share
2024-01-01	Jacques Rachelle Suzanne	Sell	29 762 300	Stock Option (Right to Buy)
2023-06-01	Jacques Rachelle Suzanne	Sell	152 690 700	Stock Option (Right to Buy)
2024-07-17	Dicicco Wendy F	Sell	5 000 000	Stock Option (Right to Buy)
2024-01-01	Patel Samir Rashmikant	Buy	0	Ordinary Shares, par value $0.0001 per share

INSIDER POWER
-100.00
Last 82 transactions
Buy: 68 941 813 \| Sell: 428 362 177

Akari Therapeutics PLC 相关性

10 最正相关
SWVL	0.972
NAKD	0.968
SNGX	0.964
GROM	0.963
DIBS	0.963
AVIR	0.962
CSSE	0.962
JAGX	0.962
PSTX	0.961
RUBY	0.96

10 最负相关
AGZD	-0.97
DXJS	-0.965
TIGO	-0.958
PRAA	-0.954
PDFS	-0.95
GPACU	-0.948
MEOH	-0.947
UNAM	-0.945
SLMBP	-0.945
PANL	-0.944

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Akari Therapeutics PLC 财务报表

Annual	2023
营收:	$0
毛利润:	$-4 000.00 (0.00 %)
EPS:	$-2.04

FY	2023
营收:	$0
毛利润:	$-4 000.00 (0.00 %)
EPS:	$-2.04

FY	2022
营收:	$0
毛利润:	$-3 708.00 (0.00 %)
EPS:	$-2.23

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.406

Financial Reports:

No articles found.

Akari Therapeutics PLC

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom.